Funding Received
$92.3 Million in 6 Rounds from 4 Investors
Most Recent Funding
$215 Thousand Grant on August 5, 2014
Headquarters:
Newark, CA
Description:
Oraya Therapeutics develops non-invasive robotically-controlled treatments for inflammatory and neovascular diseases of the eye.
Founders:
Michael Gertner, Michael Gertner
Categories:
Biotechnology
Website:
http://www.orayainc.com

Company Details

Update

Oraya Therapeutics is currently testing its first application of the IRay system. Oraya Therapeutics develops noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye.

Past Team (2)

Update

Funding Rounds (6) - $92.3M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    8000 Jarvis Ave.

    Newark, CA 94560

    USA

Images (1)

Update
  • 6b40ed0e789ef22e4979ad0871fdc93f